Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corporation（ADPT）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · ADPT · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
97
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Adaptive Biotechnologies Corporation内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
ADPT 季度内部人买卖趋势
ADPT 内幕交易卖出 · ADPT 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · ADPT CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
ADPT 高管卖出股份 · ADPT 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 18, 2026 | PISKEL KYLE CFO | Sale | 3,115 | $41K | Form 4 |
| Apr 27, 2026 | RUBINSTEIN JULIE President and COO | Option | 14,707 | $124K | Form 4 |
| Apr 27, 2026 | RUBINSTEIN JULIE President and COO | Sale | 19,037 | $271K | Form 4 |
| Apr 22, 2026 | RUBINSTEIN JULIE President and COO | Option | 14,722 | $125K | Form 4 |
| Apr 23, 2026 | RUBINSTEIN JULIE President and COO | Option | 14,722 | $125K | Form 4 |
| Apr 24, 2026 | RUBINSTEIN JULIE President and COO | Option | 14,722 | $125K | Form 4 |
| Apr 22, 2026 | RUBINSTEIN JULIE President and COO | Sale | 19,060 | $269K | Form 4 |
| Apr 23, 2026 | RUBINSTEIN JULIE President and COO | Sale | 19,060 | $262K | Form 4 |
| Apr 24, 2026 | RUBINSTEIN JULIE President and COO | Sale | 19,060 | $267K | Form 4 |
| Apr 21, 2026 | RUBINSTEIN JULIE President and COO | Option | 11,881 | $144K | Form 4 |
| Apr 17, 2026 | RUBINSTEIN JULIE President and COO | Option | 14,722 | $125K | Form 4 |
| Apr 20, 2026 | RUBINSTEIN JULIE President and COO | Option | 14,722 | $125K | Form 4 |
| Apr 21, 2026 | RUBINSTEIN JULIE President and COO | Option | 14,722 | $125K | Form 4 |
| Apr 17, 2026 | RUBINSTEIN JULIE President and COO | Sale | 19,060 | $278K | Form 4 |
| Apr 20, 2026 | RUBINSTEIN JULIE President and COO | Sale | 19,060 | $277K | Form 4 |
| Apr 21, 2026 | RUBINSTEIN JULIE President and COO | Sale | 30,941 | $454K | Form 4 |
| Apr 14, 2026 | RUBINSTEIN JULIE President and COO | Option | 14,722 | $125K | Form 4 |
| Apr 15, 2026 | RUBINSTEIN JULIE President and COO | Option | 14,722 | $125K | Form 4 |
| Apr 16, 2026 | RUBINSTEIN JULIE President and COO | Option | 14,722 | $125K | Form 4 |
| Apr 14, 2026 | RUBINSTEIN JULIE President and COO | Sale | 19,060 | $278K | Form 4 |
| Apr 15, 2026 | RUBINSTEIN JULIE President and COO | Sale | 19,060 | $278K | Form 4 |
| Apr 16, 2026 | RUBINSTEIN JULIE President and COO | Sale | 19,060 | $270K | Form 4 |
| Apr 9, 2026 | RUBINSTEIN JULIE President and COO | Option | 14,722 | $107K | Form 4 |
| Apr 10, 2026 | RUBINSTEIN JULIE President and COO | Option | 14,722 | $107K | Form 4 |
| Apr 13, 2026 | RUBINSTEIN JULIE President and COO | Option | 6,613 | $56K | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 ADPT 内幕交易
ADPT 内幕交易
Adaptive Biotechnologies Corporation（ADPT）内幕交易数据来源于公司内部人（包括RUBINSTEIN JULIE (President and COO), LO FRANCIS (CPO), ROBINS CHAD M (CEO and Chairman · Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。ADPT内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Adaptive Biotechnologies Corporation机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
ADPT 内幕交易 · 5个问题Adaptive Biotechnologies Corporation（ADPT）的内部人包括高管和董事，如RUBINSTEIN JULIE (President and COO), LO FRANCIS (CPO), ROBINS CHAD M (CEO and Chairman · Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026